Interfering with the ERC1-LL5β interaction disrupts plasma membrane-Associated platforms and affects tumor cell motility.
Ribolla LM, Sala K, Tonoli D, Ramella M, Bracaglia L, Bonomo I, Gonnelli L, Lamarca A, Brindisi M, Pierattelli R, et al. PLoS One. 2023; 18(7):e0287670. Epub 2023 Jul 12.